SEC Filing Details

Document Details

Form
Filing Date
Nov 17, 2026
Document Date
Nov 14, 2026
Form Description
Initial filing by director officer or owner of more than ten percent
Filing Group
3,4,5
Company
Lexeo Therapeutics
Issuer
LEXEO THERAPEUTICS, INC.
Filer
Schilke Tobin

Contact Us